TEMOTIL

This brand name is authorized in Nigeria.

Active ingredients

The drug TEMOTIL contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7791	Tablet	TEMOTIL TABLETS TAB 2 mg 20X5X10, 25X6,10X10	11 RNW-PP-306087 TEMOTIL TABLETS LOPERAMIDE 2MG Loperamide HCl 2mg, Maize Starch, Dibasic Calcium Phosphate, Sodium Benzoate, Sodium Lauryl Sulphate, Croscarmellose, Colloidal Anhydrous Silica, Povidone K-30, Magnesium Stearate B4-7791 Drugs Imported Products 20X5X10,25X6,10X10 Over The Counter (OTC) 2/2/2023 TEKA PHARMACEUTICALCOMPANY LTD, ,ZUNGERU ROAD, NOMANSLAND KANO KANO 7066430624 tekapharmaceuticalco@outlook.com KESAR PHARMA PRIVATE LIMITED , PLOT N0. 50-P/2, AT; BILESHWARPURA, PO.CHHATRAL, TAL; KALOL, DIST; GANDHINAGAR, GUJARAT, INDIA., India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7791